Skip to main content

Advertisement

Contact N. O’Connor-Byrne

From: Bortezomib-induced hyponatremia: tolvaptan therapy permits continuation of lenalidomide, bortezomib and dexamethasone therapy in relapsed myeloma

Contact corresponding author